Decitex 50Mg Injection
1 Powder For Injection(s) in Dry VialMRP ₹6229.39
₹4983.51
20% OFF
Made by
SUN PHARMA
Dosage
POWDER FOR INJECTION
Expiry
General Information
| Uses | Myelodysplastic syndromes: Helps manage disorders in which the bone marrow produces abnormal or insufficient blood cells, under specialist supervision., Acute myeloid leukaemia: Helps control abnormal blood-forming cells in selected adults as part of a specialist treatment plan. |
| Therapy | Anti-neoplastic |
| Side effects | Low white blood cells: Treatment can reduce infection-fighting cells, so fever, chills or a new cough needs immediate contact with the treatment team., Low platelets: Fewer clotting cells may cause bruising, nosebleeds or bleeding gums. Report bleeding that does not stop urgently., Anaemia: Reduced red blood cells can cause unusual tiredness, weakness or breathlessness. Tell the treatment team if these symptoms worsen., Nausea: Decitabine may upset the stomach during treatment. Use the anti-sickness medicine prescribed and seek help if drinking becomes difficult., Diarrhoea: Loose stools can cause dehydration during treatment. Contact the team for persistent diarrhoea, blood in stools or severe abdominal pain. |
| Salt Content | Decitabine(50.0 Mg) |
Medicines
available
19k pincodes
Medical Description
Decitex powder for injection is a specialist medicine used in selected adults with myelodysplastic syndromes or acute myeloid leukaemia, conditions that affect blood-forming cells in the bone marrow. It contains decitabine, which helps abnormal marrow cells mature more normally or die so healthier blood cells can develop. By changing abnormal growth instructions in these cells, decitabine can improve the marrow's ability to produce blood cells. Decitex powder for injection is prepared and given into a vein by a doctor or nurse in a hospital or clinic, with blood tests used to monitor treatment.
Uses
- Myelodysplastic syndromes: Helps manage disorders in which the bone marrow produces abnormal or insufficient blood cells, under specialist supervision.
- Acute myeloid leukaemia: Helps control abnormal blood-forming cells in selected adults as part of a specialist treatment plan.
Contraindications
Side effects
- Low white blood cells: Treatment can reduce infection-fighting cells, so fever, chills or a new cough needs immediate contact with the treatment team.
- Low platelets: Fewer clotting cells may cause bruising, nosebleeds or bleeding gums. Report bleeding that does not stop urgently.
- Anaemia: Reduced red blood cells can cause unusual tiredness, weakness or breathlessness. Tell the treatment team if these symptoms worsen.
- Nausea: Decitabine may upset the stomach during treatment. Use the anti-sickness medicine prescribed and seek help if drinking becomes difficult.
- Diarrhoea: Loose stools can cause dehydration during treatment. Contact the team for persistent diarrhoea, blood in stools or severe abdominal pain.
Precautions and Warnings
Pregnancy
Directions for Use
Storage and disposal
Quick Tips
- Keep every blood-test and specialist appointment.
- Report fever, chills, cough or other infection signs immediately.
- Report unusual bruising, nosebleeds or bleeding gums promptly.
- Ask before receiving any vaccine, especially a live vaccine.
- Tell the treatment team about new medicines or supplements before treatment.
Dosage
Missed a Dose
Overdose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
- No specific food restrictions are required because Decitex powder for injection is given intravenously.
- Maintain adequate fluid intake as your healthcare team advises.
- Try to avoid alcohol or discuss alcohol consumption with your doctor during treatment.
Frequently Asked Questions (FAQs)
References:
- US Food and Drug Administration (FDA). DACOGEN (decitabine) for injection, for intravenous use: Prescribing Information [Internet]. Silver Spring (MD): FDA; 2023 [cited 2026 Aug 10].
- European Medicines Agency (EMA). Dacogen (decitabine) 50 mg powder for concentrate for solution for infusion: Summary of Product Characteristics (SmPC) & Package Leaflet [Internet]. Amsterdam: EMA; 2024
- Central Drugs Standard Control Organisation (CDSCO). Approved List of Cytotoxic and Oncology Drugs - Decitabine Injection Prescribing Leaflet [Internet]. New Delhi: CDSCO, Ministry of Health and Family Welfare, Government of India; 2022
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Manufacturer Name:SUN PHARMA
Address:<p>1. 90, Delhi - Jaipur Road, Sector 32, Gurugram, Haryana 122001</p>
Country of Origin:India
Vendor Details
Fulfillment Information: Decitex 50 MG Powder For Injection (1) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
